Skip to content
healthcare.dev
Get a free key

HYALURONIDASE

NDC 51662-1555, HYALURONIDASE, injection, solution, from HF Acquisition Co LLC, DBA HealthFirst.

Product NDC
51662-1555
Status
Listed
Labeler
HF Acquisition Co LLC, DBA HealthFirst
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA021859
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1555 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYALURONIDASE (HUMAN RECOMBINANT)150 [USP'U]/mL

Pharmacologic classes

Endoglycosidase [EPC]; Glycoside Hydrolases [CS]

Package NDCNDC-11Package
51662-1555-1516621555011 VIAL in 1 BOX (51662-1555-1) / 1 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c3f1db01-58bf-2226-e053-2a95a90a8b33

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=51662-1555

Use it

Look up 51662-1555 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1555 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51662-1555. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.